Here, we observed increased K17 expression in both ACD patients and an experimental model of OXA-induced mice and that mice lacking K17 exhibited a weaker skin inflammatory response as compared with WT controls. The gene discussed is KRT17; the disease is granular corneal dystrophy type II.